China humanoid OEM (Walker S2)
UBTech Robotics
China leading humanoid firm. It began mass production and delivery of the industrial humanoid Walker S2 in Nov 2025, with 800M+ yuan in cumulative orders. H1 2025 revenue 621M yuan, with humanoid sales up 2,204% to 41% of revenue. BYD, Geely and Foxconn deploy them in factories. Targeting 5,000 units in 2026. A humanoid demand apex beyond Tesla.
9880.HK Updated Jul 12, 2026 6 AI consumers· 3 recurring
Per the valuechain.wiki graph, UBTech Robotics is directly linked to 5 companies (4 supply, 1 revenue relationships) and reaches 15 companies within two hops; the links are backed by 8 dated sources, 1 of them primary filings (as of 2026-07-12).
Financials & Segments
- Total revenue · RMB 2.001bn (FY2025, +53.3%)
- Customer concentration · Humanoid the top revenue source (full-size +2,204%); 5,000 units in 2026; BYD/Geely/Foxconn plants. BYD/Geely/Foxconn factories; 5k units in 2026.
- Segments · Industrial humanoids (Walker S2) · Consumer robots (UWORLD) · Education/service robots
Revenue from
- Foxconn (Hon Hai) High confidence
Supplies humanoids for Foxconn factory logistics. - BYD · Geely and other automakers (humanoids) High confidence
Industrial humanoids to automaker factories (BYD, Geely, FAW).
Pays to
- Harmonic Drive Systems High confidence
Adopts harmonic reducers in Walker S2 joints. - CATL Medium confidence
Adopts CATL batteries for humanoid power. - Nidec Medium confidence
Sources humanoid joint motors and actuators. - Inovance Technology Medium confidence
Sources servo and motion control from Inovance.Confirms EN Robotics & Automation News Published Sep 25, 2025: Inovance targets humanoid components and servo - AI chips · sensors · manufacturing (undisclosed) Low confidence
AI compute, sensors and assembly.
Value-chain ripple (2 tiers)
Following node-to-node links up to 2 tiers; each firm is shown once, at its nearest tier.
| Company | Chain | '21 | '22 | '23 | '24 | '25 | YTD |
|---|---|---|---|---|---|---|---|
| Apple | lead2 | +34.6 | -26.4 | +49 | +30.7 | +9.1 | +18 |
| Amazon | lead2 | +2.4 | -49.6 | +80.9 | +44.4 | +5.2 | +12 |
| Alphabet (Google) | lead2 | +65.3 | -39.1 | +58.3 | +36 | +66 | +8.3 |
| Microsoft | lead2 | +52.5 | -28 | +58.2 | +12.9 | +15.6 | +4 |
| Foxconn (Hon Hai) | lead1 | -5.1 | +2.8 | +7.8 | +80.1 | +26.9 | +19.6 |
| UBTech Robotics | node | · | · | · | -21.6 | +95.4 | -38.8 |
| Harmonic Drive Systems | benef1 | -42.7 | -2.5 | -16.1 | +24.9 | -23.8 | +68.9 |
| Nidec | benef1 | -26.8 | -28.4 | -21.9 | -1.7 | -17.4 | +18.4 |
| CATL | benef1 | +67.4 | -21.4 | -40.6 | +74.5 | +39.4 | +2.2 |
| Inovance Technology | benef1 | -5.1 | +19.2 | -20.9 | +8.4 | +24.8 | -20 |
| Yunnan Energy New Material (SEMCORP) | benef2 | +92.8 | -38.6 | -72.6 | -29.2 | +76.4 | -5.3 |
| Tinci Materials | benef2 | +68.3 | +5.6 | -61.4 | -0.7 | +124.2 | -16.2 |
| Ronbay Technology | benef2 | +96.6 | -39.1 | -63.6 | +12.3 | +47.7 | -20 |
| Chunbo | benef2 | +40.4 | -7.3 | -65 | -55.6 | +59.1 | -32.5 |
| Enchem | benef2 | · | -37.4 | +173.9 | -20.5 | -26.1 | -79 |
YTD as of 2026-09-04 · source: Yahoo Finance
UBTech Robotics operates across China humanoid OEM (Walker S2). After +95.4% in 2025, it gave back -38.8% in 2026. The supply side (avg +17.4%) has moved harder than the stock (-38.8%). That is the classic bottleneck pattern: supplier volume leverage is being priced before this layer's own margin. Among connected nodes the furthest ahead is Harmonic Drive Systems (+68.9%) and the furthest behind is Inovance Technology (-20%). If chain logic explains the gap, the laggard is the next propagation candidate; if not, the link itself deserves a second look. A humanoid demand apex beyond Tesla.
Analysis generated from returns as of 2026-09-04Analyst ratings
Consensus: Buy 2 · Hold 0 · Sell 0 · Avg. target HK$139 · Price HK$85.65 (09-04) · Upside +62%
| Broker | Rating | Target | Published | |
|---|---|---|---|---|
| JPMorgan | Overweight | HK$156 | Jun 16, 2026 | Report ↗ |
| Citi | Buy | HK$121 | Sep 1, 2025 | Report ↗ |
On the back of surging humanoid robot revenue, JPMorgan and Citi maintain bullish calls; consensus is Strong Buy with an average target around HKD 158.